Citadel Advisors - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,570,046
-21.1%
76,105
+12.9%
0.00%
Q2 2023$1,989,063
-93.9%
67,403
-95.2%
0.00%
-100.0%
Q1 2023$32,457,024
+1586.2%
1,408,725
+1935.3%
0.01%
Q4 2022$1,924,814
-27.5%
69,213
-20.0%
0.00%
Q3 2022$2,656,000
-72.9%
86,537
-74.0%
0.00%
-100.0%
Q2 2022$9,783,000
-60.0%
332,402
-56.3%
0.00%
-60.0%
Q1 2022$24,488,000
+2.0%
761,203
+41.4%
0.01%
+25.0%
Q4 2021$24,008,000
+358.8%
538,283
+419.0%
0.00%
+300.0%
Q3 2021$5,233,000
+101.0%
103,711
+212.4%
0.00%
Q2 2021$2,604,000
-83.5%
33,200
-88.0%
0.00%
-100.0%
Q1 2021$15,765,000
+254.3%
276,084
+419.8%
0.00%
+200.0%
Q4 2020$4,449,000
-48.2%
53,113
-77.8%
0.00%
-50.0%
Q3 2020$8,583,000
+221.1%
239,537
+116.6%
0.00%
+100.0%
Q2 2020$2,673,000
+80.4%
110,565
+30.6%
0.00%0.0%
Q1 2020$1,482,000
+27.4%
84,652
+26.8%
0.00%
Q4 2019$1,163,000
-23.8%
66,786
-33.0%
0.00%
-100.0%
Q3 2019$1,526,000
-62.3%
99,609
-48.9%
0.00%
-50.0%
Q2 2019$4,045,000
+527.1%
194,876
+601.9%
0.00%
Q1 2019$645,000
-14.3%
27,765
-43.8%
0.00%
Q2 2018$753,00049,4210.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders